The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 6, 2026 | Mahal Jeetinder Singh | CEO and President, Director | Grant(A) | 500K | — | $0 |
| Jan 2, 2026 | Cross Herb | Chief Financial Officer | Grant(A) | 90K | — | $0 |
| Jan 2, 2026 | Mahal Jeetinder Singh | Chief Operating Officer | Grant(A) | 90K | — | $0 |
| Jan 2, 2026 | Martell Ron | President, CEO and Director, Director | Grant(A) | 234K | — | $0 |
| Sep 22, 2025 | Shizuru Judith Anne | Director | Buy(P) | 41K | $2.43 | $100K |
| Sep 22, 2025 | Shizuru Judith Anne | Director | Buy(P) | 41K | — | — |
| Sep 22, 2025 | Martell Ron | President and CEO, Director | Buy(P) | 41K | $2.43 | $100K |
| Sep 22, 2025 | Martell Ron | President and CEO, Director | Buy(P) | 41K | — | — |
| Sep 22, 2025 | Lucas Svetlana | Director | Buy(P) | 20K | $2.43 | $49K |
| Sep 22, 2025 | Lucas Svetlana | Director | Buy(P) | 20K | — | — |
| Sep 22, 2025 | Wiggans Thomas G | Director | Buy(P) | 41K | $2.43 | $100K |
| Sep 22, 2025 | Wiggans Thomas G | Director | Buy(P) | 41K | — | — |
| Jul 3, 2025 | Lucas Svetlana | Director | Grant(A) | 8K | — | $0 |
| Jul 3, 2025 | Wiggans Thomas G | Director | Grant(A) | 8K | — | $0 |
| Jul 3, 2025 | Kapoor Vishal | Director | Grant(A) | 8K | — | $0 |
| Jul 3, 2025 | Nolet Chris | Director | Grant(A) | 8K | — | $0 |
| Jul 3, 2025 | Shizuru Judith Anne | Director | Grant(A) | 8K | — | $0 |
| Jul 3, 2025 | Emster Kurt Von | Director | Grant(A) | 8K | — | $0 |
| Jul 3, 2025 | Brun Scott C. | Director | Grant(A) | 8K | — | $0 |
| Jun 4, 2025 | Tucker Edwin Jonathan | Chief Medical Officer | Grant(A) | 90K | — | $0 |
| Jun 4, 2025 | Cross Herb | Chief Financial Officer | Grant(A) | 90K | — | $0 |
| Jun 4, 2025 | Mahal Jeetinder Singh | Chief Operating Officer | Grant(A) | 90K | — | $0 |
| Jun 4, 2025 | Martell Ron | President and CEO, Director | Grant(A) | 234K | — | $0 |
| Feb 13, 2025 | Tucker Edwin Jonathan | Chief Medical Officer | Grant(A) | 50K | — | $0 |
| Feb 13, 2025 | Cross Herb | Chief Financial Officer | Grant(A) | 50K | — | $0 |
| Feb 13, 2025 | Martell Ron | President, CEO and Director, Director | Grant(A) | 130K | — | $0 |
| Feb 13, 2025 | Mahal Jeetinder Singh | Chief Operating Officer | Grant(A) | 50K | — | $0 |
| Dec 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | Option exercise(M) | 900 | $7.10 | $6K |
| Dec 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | Sell(S) | 900 | $22.11 | $20K |
| Dec 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | Option exercise(M) | 900 | — | $0 |
| Sep 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | Sell(S) | 900 | $21.23 | $19K |
| Sep 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | Option exercise(M) | 900 | $7.10 | $6K |
| Sep 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | Option exercise(M) | 900 | — | $0 |
| Jun 18, 2024 | Lucas Svetlana | Director | Grant(A) | 15K | — | $0 |
| Jun 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | Sell(S) | 900 | $24.16 | $22K |
| Jun 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | Option exercise(M) | 900 | $7.10 | $6K |
| Jun 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | Option exercise(M) | 900 | — | $0 |
| Jun 10, 2024 | Martell Ron | President, CEO and Director, Director | Grant(A) | 20K | — | $0 |
| Jun 10, 2024 | Martell Ron | President, CEO and Director, Director | Grant(A) | 10K | — | $0 |
| Jun 7, 2024 | Tucker Edwin Jonathan | Chief Medical Officer | Grant(A) | 400 | $4.17 | $2K |
| Jun 6, 2024 | Emster Kurt Von | Director | Grant(A) | 8K | — | $0 |
| Jun 6, 2024 | Brun Scott C. | Director | Grant(A) | 8K | — | $0 |
| Jun 6, 2024 | Wiggans Thomas G | Director | Grant(A) | 8K | — | $0 |
| Jun 6, 2024 | Kapoor Vishal | Director | Grant(A) | 8K | — | $0 |
| Jun 6, 2024 | Shizuru Judith Anne | Director | Grant(A) | 8K | — | $0 |
| Jun 6, 2024 | Nolet Chris | Director | Grant(A) | 8K | — | $0 |
| Jun 6, 2024 | French Anna Louise | Director | Grant(A) | 8K | — | $0 |
| Mar 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | Sell(S) | 900 | $26.44 | $24K |
| Mar 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | Option exercise(M) | 900 | $7.10 | $6K |
| Mar 12, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | Option exercise(M) | 900 | — | $0 |
| Feb 15, 2024 | Tucker Edwin Jonathan | Chief Medical Officer | Grant(A) | 45K | — | $0 |
| Feb 15, 2024 | Cross Herb | Chief Financial Officer | Grant(A) | 40K | — | $0 |
| Feb 15, 2024 | Mahal Jeetinder Singh | Chief Operating Officer | Grant(A) | 40K | — | $0 |
| Feb 15, 2024 | Martell Ron | President, CEO and Director, Director | Grant(A) | 100K | — | $0 |
| Feb 8, 2024 | Venkataraman Balaji | 10% Owner | Buy(P) | 350K | $12.95 | $4.5M |
| Feb 8, 2024 | Abingworth LLP | 10% Owner | Buy(P) | 190K | $12.95 | $2.5M |
| Nov 28, 2023 | Wiggans Thomas G | Director | Buy(P) | 10K | $0.65 | $7K |
| Nov 21, 2023 | Wiggans Thomas G | Director | Buy(P) | 10K | $0.64 | $6K |
| Nov 20, 2023 | Wiggans Thomas G | Director | Buy(P) | 10K | $0.63 | $6K |
| Nov 17, 2023 | Wiggans Thomas G | Director | Buy(P) | 10K | $0.60 | $6K |
| Nov 16, 2023 | Wiggans Thomas G | Director | Buy(P) | 10K | $0.60 | $6K |
| Nov 1, 2023 | Wiggans Thomas G | Director | Grant(A) | 110K | — | $0 |
| Oct 13, 2023 | Lis William | Director | Sell(S) | 8K | $0.85 | $7K |
| Oct 12, 2023 | Martell Ron | President, CEO & Director, Director | Tax withholding(F) | 88K | $0.85 | $74K |
| Oct 12, 2023 | Mahal Jeetinder Singh | Chief Operating Officer | Tax withholding(F) | 37K | $0.85 | $32K |
| Sep 22, 2023 | Cross Herb | Chief Financial Officer | Grant(A) | 550K | — | $0 |
| Jun 20, 2023 | Brun Scott C. | Director | Grant(A) | 94K | — | $0 |
| Jun 13, 2023 | Mahal Jeetinder Singh | See Remarks | Sell(S) | 9K | $1.66 | $15K |
| Jun 13, 2023 | Mahal Jeetinder Singh | See Remarks | Option exercise(M) | 9K | $0.71 | $6K |
| Jun 13, 2023 | Mahal Jeetinder Singh | See Remarks | Option exercise(M) | 9K | — | $0 |
| Jun 12, 2023 | Tucker Edwin Jonathan | Chief Medical Officer | Grant(A) | 400K | — | $0 |
| Jun 7, 2023 | French Anna Louise | Director | Grant(A) | 47K | — | $0 |
| Jun 7, 2023 | Lis William | Director | Grant(A) | 47K | — | $0 |
| Jun 7, 2023 | Nolet Chris | Director | Grant(A) | 47K | — | $0 |
| Jun 7, 2023 | Shizuru Judith Anne | Director | Grant(A) | 47K | — | $0 |
| Jun 7, 2023 | Emster Kurt Von | Director | Grant(A) | 47K | — | $0 |
| Jun 7, 2023 | Klein Lawrence Otto | Director | Grant(A) | 47K | — | $0 |
| Jun 7, 2023 | Kapoor Vishal | Director | Grant(A) | 47K | — | $0 |
| Apr 14, 2023 | French Anna Louise | Director | Sell(S) | 7K | $1.48 | $10K |
| Apr 13, 2023 | Lis William | Director | Sell(S) | 9K | $1.44 | $12K |
| Apr 13, 2023 | Emster Kurt Von | Director | Sell(S) | 9K | $1.49 | $14K |
| Apr 12, 2023 | Mahal Jeetinder Singh | See Remarks | Tax withholding(F) | 37K | $1.46 | $54K |
| Apr 12, 2023 | Martell Ron | President, CEO and Director, Director | Tax withholding(F) | 88K | $1.46 | $128K |
| Mar 17, 2023 | Martell Ron | President, CEO and Director, Director | Grant(A) | 500K | — | $0 |
| Mar 17, 2023 | Mahal Jeetinder Singh | See Remarks | Grant(A) | 350K | — | $0 |
| Feb 16, 2023 | Kapoor Vishal | Director | Grant(A) | 109K | — | $0 |
| Feb 2, 2023 | Martell Ron | President, CEO & Director, Director | Grant(A) | 1.1M | — | $0 |
| Jan 27, 2023 | Qiming U.S. Healthcare GP II, LLC | 10% Owner | Buy(P) | 2.7M | $1.50 | $4.0M |
| Jan 27, 2023 | TC Group, LLC | 10% Owner | Buy(P) | 3.1M | $1.50 | $4.7M |
| Jan 25, 2023 | Roche Finance Ltd | 10% Owner | Sell(S) | 75K | $1.89 | $142K |
| Oct 12, 2022 | French Anna Louise | Director | Grant(A) | 31K | — | $0 |
| Oct 12, 2022 | Lis William | Director | Grant(A) | 30K | — | $0 |
| Oct 12, 2022 | Nolet Chris | Director | Grant(A) | 33K | — | $0 |
| Oct 12, 2022 | Mahal Jeetinder Singh | See Remarks | Grant(A) | 215K | — | $0 |
| Oct 12, 2022 | Shizuru Judith Anne | Director | Grant(A) | 30K | — | $0 |
| Oct 12, 2022 | Emster Kurt Von | Director | Grant(A) | 30K | — | $0 |
| Oct 12, 2022 | Klein Lawrence Otto | Director | Grant(A) | 25K | — | $0 |
| Oct 12, 2022 | Martell Ron | President, CEO and Director, Director | Grant(A) | 506K | — | $0 |
| Jun 27, 2022 | Lis William | Director | Sell(S) | 25K | $2.08 | $51K |
| Jun 24, 2022 | Lis William | Director | Sell(S) | 25K | $2.02 | $50K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).